Integer Holdings Gross Margin 2010-2022 | ITGR

Current and historical gross margin for Integer Holdings (ITGR) over the last 10 years. The current gross profit margin for Integer Holdings as of March 31, 2022 is %.
Integer Holdings Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2022-03-31 $1.24B $0.33B 26.89%
2021-12-31 $1.22B $0.34B 27.60%
2021-09-30 $1.18B $0.33B 27.87%
2021-06-30 $1.11B $0.30B 27.46%
2021-03-31 $1.04B $0.27B 26.38%
2020-12-31 $1.07B $0.29B 26.65%
2020-09-30 $1.13B $0.29B 25.58%
2020-06-30 $1.20B $0.32B 27.05%
2020-03-31 $1.27B $0.36B 28.54%
2019-12-31 $1.26B $0.36B 28.20%
2019-09-30 $1.24B $0.37B 29.69%
2019-06-30 $1.24B $0.37B 29.59%
2019-03-31 $1.24B $0.37B 29.75%
2018-12-31 $1.21B $0.36B 29.90%
2018-09-30 $1.14B $0.36B 31.63%
2018-06-30 $1.12B $0.36B 31.90%
2018-03-31 $1.08B $0.35B 31.95%
2017-12-31 $1.14B $0.35B 31.07%
2017-09-30 $0.96B $0.32B 33.44%
2017-06-30 $1.02B $0.33B 32.32%
2017-03-31 $1.09B $0.34B 30.97%
2016-12-31 $1.08B $0.34B 31.35%
2016-09-30 $1.35B $0.36B 26.62%
2016-06-30 $1.15B $0.31B 27.25%
2016-03-31 $0.97B $0.27B 28.19%
2015-12-31 $0.80B $0.24B 29.34%
2015-09-30 $0.65B $0.22B 33.54%
2015-06-30 $0.68B $0.23B 33.19%
2015-03-31 $0.68B $0.23B 33.33%
2014-12-31 $0.69B $0.23B 33.58%
2014-09-30 $0.70B $0.23B 33.24%
2014-06-30 $0.69B $0.23B 33.14%
2014-03-31 $0.69B $0.23B 33.04%
2013-12-31 $0.66B $0.22B 32.98%
2013-09-30 $0.65B $0.21B 33.13%
2013-06-30 $0.64B $0.21B 32.71%
2013-03-31 $0.64B $0.20B 32.13%
2012-12-31 $0.65B $0.20B 31.27%
2012-09-30 $0.63B $0.20B 31.00%
2012-06-30 $0.60B $0.19B 31.00%
2012-03-31 $0.58B $0.18B 31.21%
2011-12-31 $0.57B $0.18B 31.75%
2011-09-30 $0.56B $0.18B 32.09%
2011-06-30 $0.56B $0.18B 32.37%
2011-03-31 $0.55B $0.18B 32.36%
2010-12-31 $0.53B $0.17B 32.46%
2010-09-30 $0.53B $0.17B 32.51%
2010-06-30 $0.52B $0.17B 32.31%
2010-03-31 $0.51B $0.16B 31.91%
2009-12-31 $0.52B $0.17B 31.80%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $2.383B $1.221B
Integer Holdings Corporation manufactures and develops medical devices and components primarily for original equipment manufacturers, which depend on it to design, develop and produce intellectual property protected medical device technologies. Integer Holdings operates through two segments: Medical Sales and Non-Medical Sales. Medical Sales has three sub-segments Advanced Surgical, Orthopedics and Portable Medical; Cardio and Vascular; and Cardiac Rhythm Management & Neuromodulation.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.627B 21.80
Edwards Lifesciences (EW) United States $60.552B 42.53
Alcon (ALC) Switzerland $35.080B 30.59
STERIS (STE) Ireland $21.113B 26.67
Fresenius Medical Care AG KGaA (FMS) Germany $14.716B 13.22
Teleflex (TFX) United States $11.964B 19.12
Globus Medical (GMED) United States $5.873B 29.30
Penumbra (PEN) United States $4.736B 299.29
Glaukos (GKOS) United States $2.256B 0.00
Nevro (NVRO) United States $1.608B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.313B 23.51
Paragon 28 (FNA) United States $1.281B 0.00
Artivion (AORT) United States $0.772B 83.52